The Importance of IC50 Determination
The pharmaceutical industry relies on the products it develops. A major factor that heavily affects the success of these [...]
The Role of Effective Project Management in Contract Research
On average it takes 10 years to bring a drug to market. In many cases a decade is long [...]
Feature Selection for Drug Discovery
When it comes to drug discovery, the mechanism of action for a treatment is sometimes poorly understood or not [...]
Visikol to Present at the 5th Annual Drug Discovery & Development Conference
Labroots Drug Discovery & Development 2022 Labroots and the Drug Discovery planning committee are pleased [...]
The OMICs at Visikol: monitoring the biological system’s real-time changes to advance the drug discovery process
Visikol has expanded its drug discovery services by adding liquid chromatography coupled with a tandem mass spectrometer (LC-MS/MS) facility [...]
Visikol Multiplex Technology and the Drug Discovery Process
Consumers across the world benefit from having access to the safest and most advanced drug discovery system. Every country [...]
Multiplex Cell Painting Assay for Pathological Diagnosis of Cells
Many human diseases are caused by morphological, physiological or genetic changes in cells. The challenges of disease diagnosis include [...]
HUREL Models Assist in the Evaluation of Hepatoxicity
Many drug candidates fail during clinical trials and post-market withdrawal due to hepatoxicity or Drug Induced Liver Injury (DILI). [...]
Visikol Continues to Expand Imaging Capabilities with an Additional High-Content Confocal Imager
Visikol has added an additional ImageXpress® Micro Confocal High-Content Imaging System from Molecular Devices to its robust imaging capabilities [...]
When will organs on a chip and advanced in vitro systems catch on in drug discovery?
Every week we see a new company or publication describing an advanced in vitro system for replacing the use [...]